Why did domestic pharmaceutical companies decide to ‘import’ generic products?

Domestic pharmaceutical companies focusing on the production of generic products have been reversely being importing generics. The phenomenon is interpreted as their strategy to resolve dilemma in development and to preoccupy superiority in market competition.

Last month, Shin Poong Pharm launched ‘Temolde Cap,’ a generic product of the first domestic brain tumor treatment, ‘Temodal Cap(temozo...